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Mets-enkephalin - a pentapeptide (Tyr-Gly-Gly-Phe-Met) - can exist in two possible folded arrangements 
with a rigid two-hydrogen-bonded network. In one arrangement, a Gly 2-Gly 3 p-bend is formed and in 
the other a Gly 3-Phe 4 /?-bend. The two conformations are distinguished by the spatial relation of Tyr 
1 and Phe 4: in the Gly 2-Gly 3 P-bend, Tyr 1 and Phe 4 can be brought close to each other while in the 
Gly 3-Phe 4 b-bend they are far apart (> 5 A). We have utilized one-dimensional (1D) nuclear Overhauser 
effect (NOE) measurements between the ring protons of Tyr 1 and Phe 4 to determine their proximity. The 
NOE data clearly show that a pair protons, one each from Tyr 1 and Phe 4, are as close as 3.3 A while 
other inter-proton distances are beyond 4.5 A. Therefore, we propose the presence of a Gly 2-Gly 3 /?-bend 
(in which Tyr 1 and Phe 4 are spatially close) for Mets-enkephalin in solution. The structure of Mets-en- 
kephalin in solution is very similar to the single crystal structure of Leus-enkephalin and tends to explain 
the biological activity data of several modified enkephalins. 
Nuclear Overhauser eflect Enkephalin 
1. INTRODUCTION 
Enkephalin, an endogenous morphine-like 
substance, is a mixture of two pentapeptides, i.e. 
Tyr-Gly-Gly-Phe-Met (Met’-enkephalin) and Tyr- 
Gly-Gly-Phe-Leu (Let.?-enkephalin) [ 11. In view of 
the fact that enkephalin operates at the same recep- 
tor sites as natural morphine-like opiates [2], it is 
of interest to examine whether it has a very rigid 
structure like morphine [3]. Although there has 
been an accumulation of considerable data from 
both theoretical [4- 1 l] and experimental [ 12- 161 
studies, there is a general lack of agreement re- 
garding the solution conformation of 
Met’/Leu’-enkephalin. Models of enkephalin pro- 
posed so far [4-161 fall into two distinct types, 
both involving a P-bend but one with Gly 2 and 
Gly 3 at the corners of the &bend in which Tyr 1 
and Phe 4 are spatially close (fig.1) whereas the 
other has a Gly 3-Phe 4 bend in which Tyr 1 and 
Phe 4 are far apart (fig.2). Note that in both 
Mets-enkephalin Conformation 
models, 4 of the 5 amino acids are rigidly held by 
a two-hydrogen-bonded network (figs 1,2). Our 
goal was to determine which model is the most 
likely in solution. 
2. EXPERIMENTAL 
The distinguishing feature of the two models is 
the spatial relation of Tyr 1 and Phe 4, i.e. in one 
model (fig.1) they are close to each other whereas 
in the other (fig.2) they are far apart. The proximi- 
ty of the ring protons of Tyr 1 and Phe 4 can be 
monitored by observing the primary NOE at the 
Tyr 1 ring protons from Phe 4 ring protons and 
vice versa. We conducted our NOE experiments at 
20°C for a dilute solution of Met’-enkephalin 
(1 mM, pH 7.0) in DzO such that intermolecular 
aggregation was prevented but at the same time in- 
tramolecular hydrogen bonds were retained (en- 
sured by monitoring the amide protons of 
enkephalin in water). All the NMR experiments 
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were conducted at 500 MHz. Assignment of all the 
non-exchangeable protons belonging to the 5 
amino acids of Met5-enkephaIin was done by use 
of 2D COSY experiments (not shown) and a 
discussion of these is beyond the scope of this 
paper. 
3. RESULTS 
3.1. NOE results 
For our experimental design, the aromatic pro- 
tons of Tyr 1 and Phe 4 were of interest. As shown 
in fig_3A, 5 ring protons of Phe 4 appear at lower 
field as a multiplet (2: 1:2) centered at 7.34, 7.30 
and 7.26 ppm and Tyr 1 ring protons as a set of 
two doublets (1 : 1) centered at 7.15 and 6.86 ppm. 
When the signal of Tyr 1 at 7.15 ppm was ir- 
radiated a strong NOE was observed at 7.26 ppm 
of Phe 4 (fig.3B). Weak but noticeable NOES were 
observed at 7.30 and 7.34 ppm of Phe 4. This 
could originate either as a secondary NOE from 
the site at 7.26 ppm or as a primary NOE between 
sites at 7.15 ppm of Tyr 1 and at 7.30 and 
7.34 ppm of Phe 4 (distance >4 A); however, the 
important conclusion from fig.3B is that the pro- 
ton of Tyr 1 at 7.15 ppm and that of Phe 4 at 
7.26 ppm are close in space (-3 A). This point was 
re-confirmed by performing a reciprocal NOE ex- 
periment (fig.3C) in which the signal at 7.26 ppm 
(Phe 4) was irradiated. It was interesting to observe 
that NOE was observed only at 7.15 ppm (but not 
at 6.86 ppm) of Tyr 1. This clearly revealed that 
the proton of Phe 4 at 7.26 ppm is close to that of 
Tyr 1 at 7.15 ppm and the proton of Tyr 1 at 
246 
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Fig.1. Two mutually perpendicular projections of Mets-enkephalin in the type I’ P-bend arrangement. In projection 
A, the two-hydrogen-bonded peptide skeleton lies in the plane of the paper while in B the peptide skeleton is 
perpendicular. The a-atoms of the 5 amino acid residues are indicated. The torsion angles (designated as 4, and 4, (“) 
around the N-C? and CP-C bonds) for this folded structure are: q5~ = 60, $2 = - 20; 43 = 130, $3 = 5; @4 = - 135, 
&d = 180. Note that, in this folded arrangement, in addition to two straight hydrogen bonds between Tyr 1 and Phe 
4, there is a bifurcated hydrogen bond between -C = 0 of Tyr 1 and N-H of Gly 2 which might render additional stability 
to the molecule. For clarity, the bifurcated hydrogen bonds are not shown. Also, no hydrogen bonds are shown in B. 
The most interesting feature of this structure is the proximity of the two ring protons, one each from Tyr 1 and Phe 
4, which is consistent with the NOE data of fig.3. In this structural arrangement, Tyr 1 and Phe 4 lie on one side of 
the peptide skeleton while Met 5 is on the opposite side. The hydrogen bonding schemes hown here (A) and in fig.2A 
are those proposed from extensive studies [4-161 and we have made attempts to reinvestigate these. 
6.86 ppm is far away from the Phe 4 ring protons 
(which was also re-affirmed by irradiating the 
signal at 6.86 ppm and observing no NOE at Phe 
4 ring protons; not shown). 
3-Phe 4 P-bend which keeps the Phe 4 and Tyr 1 
far apart and suggests a B-bend arrangement 
centered at Gly 2 and Gly 3 (fig.1) either as a type 
I P-bend or its mirror image type I’ [17] in which 
3.2. Molecular model building 
The NOE data unequivocally rule out the 
possibility of a structure in fig.2 involving a Gly 
Tyr 1 and Phe 4 are spatially close. In the type I p- 
bend, the torsion angles are 42 - - 60”, $2 - - 30” 
and #3 -9O”, $3 0” (fig.l). Since glycine is an 
achiral amino acid, both type I and type I ’ &bends 
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Fig.2. Two mutually perpendicular orientations of Met ‘-enkephalin in the type I &bend. In projection A, the two- 
hydrogen-bonded peptide skeleton lies in the plane of the paper while in B it is perpendicular. Torsion angles (“) for 
the folded structure: 62 = 178, $2 = 170; 43 = -57, 43 = -‘5; 4 4 = - 112, & = 8; q55 = 125, $5 = 184. Note that, 
in this model too in addition to the hydrogen bonds shown there is a possibility of a bifurcated hydrogen bond between 
-C =O of GIy 2 ahd Met 5, However, the ring protons of Tyr 1 and Phe 4 are always far apart and thus such a structural 
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Fig.3. Aromatic region of the 500 MHz ‘H-NMR 
spectra of Met5-enkephalin in D20 at 20°C; peptide 
concentration 1 mM; pH 7.0. (A) Aromatic proton 
region of Met’-enkephalin showing 5 protons of Phe 4 
and 4 of Tyr 1. Note that 5 protons of Phe 4 appear as 
multiplets (2: 1:2) centered at 7.34, 7.30 and 7.26 ppm 
while 4 protons of Tyr 1 appear as two doublets (1: 1) 
centered at 7.15 and 6.86 ppm. (B) NOE difference 
spectrum of Met’-enkephalin when the signal at 
7.15 ppm (Tyr 1) is irradiated for 300 ms. Note that the 
signal at 7.26 ppm (Phe 4) is the most prominent site of 
NOE, suggesting that the proton at 7.15 ppm (of Tyr 1) 
is close in space with the proton at 7.26 ppm (of Phe 4). 
(C) NOE difference spectrum of Mets-enkephalin when 
the signal at 7.26 ppm (Phe 4) is irradiated for 300 ms. 
Note that there is a strong NOE at 7.15 ppm of Tyr 1 
(and at other ring protons of Phe 4 as expected) but no 
trace of NOE at 6.86 ppm of Tyr 1. This suggests that 
only the proton at 7.15 ppm (of Tyr 1) and not the one 
at 6.86 ppm (of Tyr 1) is close to the proton at 7.26 ppm 
(of Phe 4). When the peak at 7.15 ppm (Tyr 1) is 
irradiated (spectrum B), NOE is expected at 6.86 ppm of 
Tyr 1 which is present in the spectrum but skewed due 
to loss of a data point. 
are stereochemically equally probable in fig. 1. 
However, for reasons given below, we prefer the 
type 1’ P-bend for Met’-enkephalin. The type I ’ ,L% 
bend has been observed for Let?-enkephalin in the 
single crystal [16] and it has been well 
demonstrated that Leu’/Me?-enkephalin show 
similar activity towards opiate receptors [l-3]. 
Substitution of D-Ala for Gly 2 resulted in similar 
biological activity to that of the parent compound 
Met’/Leu’-enkephalin [ 181. In view of the fact that 
D-Ala tends to prefer stereochemically the type I ’ 
P-bend, it is not unlikely that Met’-enkephalin in 
the active conformation adopts the type I’ P-bend. 
Models were generated for Met’-enkephalin in the 
type I ’ &bend conformation subject to the follow- 
ing constraints: 
(i) stereochemically acceptable hydrogen bonds 
were formed between Tyr 1 N-H and Phe 4 C = 0 
and between Tyr 1 C= 0 and Phe 4 N-H, i.e. 
N...O -2.8 A and N-H---O < 10”; 
(ii) Tyr 1 and Phe 4 aromatic rings were oriented 
in such a way that the distances between the two 
ring protons were consistent with the NOE data; 
(iii) it was ensured that no model had any steric 
compression. 
Fig. 1 shows the final model of Met’-enkephalin; 
note that only one proton belonging to Tyr 1 is 
close to only one proton of Phe 4 (distance 
-3.3 A); all other inter-proton distances between 
the two rings are r4 A. In fig.2, another possible 
model of enkephalin is shown; this involves a type 
I P-bend with Gly 3 and Phe 4 at the corners of the 
bend and thus with Phe 4 and Tyr 1 far apart. 
4. CONCLUSIONS 
NOE measurements aided by computer model 
building enable us to suggest hat Met’-enkephalin 
forms a type I ’ P-bend in solution like 
Let?-enkephalin in the crystal [ 161. It turns out 
that in our model only D-amino acids can be 
substituted for Gly 2 such that there is no steric 
compression; this is interesting in view of the fact 
that replacement of Gly 2 by D-Ala/D-Thr is 
known to retain/enhance the biological activity of 
the molecule [ 18-201. It may also be mentioned 
that in our model only Gly could be accom- 
modated stereochemically at the 3rd position - it 
has been reported that the Gly substitution in 
Leu5/Met5-enkephalin results in the loss of 
biological activity [ 19,201. Thus, our solution 
model of Met’-enkephalin based upon NOE is 
stereochemically acceptable and appears to explain 
the biological activity of the molecule on a struc- 
tural basis. 
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